Camille Chang Gilmore, Boston Scientific’s global chief DEI officer announced she is leaving the company after two decades of ...

BiVacor announced today that it received FDA breakthrough device designation for its Total Artificial Heart (TAH) system.

Reflow Medical received FDA de novo clearance for its Spur Peripheral Retrievable Stent System for infrapopliteal arterial ...

BioSig has merged with Streamex Exchange Corp. in a move that will take the British Columbia–based commodities tokenization ...

Add Medtronic to the growing list of companies and institutions rolling back the work-from-home movement that outlasted the ...

Dentsply Sirona this week announced it appointed Matthew Garth as EVP and chief financial officer, effective today.

Terumo Interventional Systems has announced the early commercial availability of its FDA-approved Roadsaver Carotid Stent ...

Vivani Medical (Nasdaq:VANI) announced that it filed a Form 10 registration statement with the SEC to spin off its ...

Abbott published findings from the AVEIR DR i2i study evaluating the company's novel dual-chamber leadless pacemaker (LP) ...

HistoSonics announced that its Edison histotripsy system for noninvasively destroying liver tumors has secured early U.K..

Reuters reports that Neuralink raised another $600 million in a deal that values the company at $9 billion before the ...

CoreMap announced that it received FDA investigational device exemption (IDE) to extend its electrophysiology (EP) mapping ...